iSpecimen (ISPC) Notes Payables (2020 - 2024)

iSpecimen (ISPC) posted quarterly Notes Payables of $864425.0 for Q3 2024, up 5.85% quarter-over-quarter from $816667.0 in Q3 2022.

iSpecimen (ISPC) Notes Payables (2020 - 2024) Analysis & Trends

iSpecimen's Notes Payables history runs 3 years deep, the most recent figure standing at $864425.0 for Q3 2024.

In Q3 2024, Notes Payables changed N/A year-over-year to $864425.0; the TTM figure through Sep 2024 stood at $864425.0 (changed N/A YoY), while the FY2020 annual figure was $2.4 million, changed N/A from the prior year.
Notes Payables for Q3 2024 stood at $864425.0, up from $816667.0 in the prior quarter.
The five-year high for Notes Payables was $2.4 million in Q4 2020, with the low at $466667.0 in Q2 2022.
The 3-year median for Notes Payables is $840546.0 (2022), against an average of $1.1 million.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Thermo Fisher Scientific	213.40 Bn	209.33 Bn	8.34 Bn
2	Danaher	139.94 Bn	135.59 Bn	3.61 Bn
3	Idexx Laboratories	46.03 Bn	45.83 Bn	779.09 Mn
4	Agilent Technologies	39.69 Bn	37.88 Bn	990.00 Mn
5	Iqvia Holdings	39.32 Bn	37.24 Bn	1.44 Bn
6	Natera	38.47 Bn	37.37 Bn	696.04 Mn
7	Illumina	29.98 Bn	28.82 Bn	770.00 Mn
8	Mettler Toledo International	28.57 Bn	28.52 Bn	650.22 Mn
9	Quest Diagnostics	26.21 Bn	25.58 Bn	1.03 Bn
10	iSpecimen	692,995.30	-2.13 Mn	71,599.00

Download Data